UNH
UNH jumped 3.5 percent today after an earnings beat and a guidance raise — and in managed care, that combination almost always moves the stock hard. Insurance companies see their cost trends months ahead of the market, so when management upgrades the outlook, they're usually working from data nobody else has yet. The story isn't entirely clean, though. Commercial insurance margins are getting squeezed by a federal rule around provider dispute resolution, and when analysts grilled management on the recovery timeline, the answer came back: past 2027. The market shrugged it off. Here's the hidden exposure most investors never think about: healthcare ETFs can quietly hold up to 22 percent in UNH alone. If you own a broad health fund, check that weight before assuming you're diversified. Commercial margins are the number to watch.
-1.5% — UnitedHealth: Margin Recovery Is Priced In, Growth Is The Next Test
-1.6% — Can UNH's Lower Medical Costs Sustain the Earnings Recovery?
-1.6% — UnitedHealth's Medicare Recovery Is Accelerating And Has More Room To Run
-2.1% — Moved with the tape — no single reported reason that day.
-1.9% — UnitedHealth Group (UNH) Expands Tennessee Health Hubs With $4 Million Commitment
-1.7% — UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?
-1.9% — UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?
+2.7% — UnitedHealth Group Incorporated (UNH) and Intuitive Surgical, Inc. (ISRG) Just Showed Why Beating Estimates Is
-1.8% — UnitedHealth, Ardagh Metal Packaging, Nvidia And More: CNBC’s ‘Final Trades’
+3.5% — What Kept Coming Up When Analysts Grilled UNH
-1.6% — UnitedHealth’s Stock Run Is Strong. Earnings Will Gauge Medicare Advantage Recovery.
-1.6% — Can UNH's Lifestyle Spending Account Redefine Employee Benefits?
+2.4% — External audit of UnitedHealth senior home visits finds most diagnoses supported by medical data
-1.7% — UnitedHealth Bets on Profitability Over Growth: Will It Pay Off?
+2.6% — UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
-1.9% — Top Research Reports for UnitedHealth, BlackRock & Salesforce
+3.0% — UnitedHealth is Near its 52-Week High. Wall Street Is Starting to Notice This Blue Chip Stock -- and So Should
+2.4% — What to Expect From UnitedHealth Group's Q2 2026 Earnings Report
-2.0% — Moved with the tape — no single reported reason that day.
+1.6% — Moved with the tape — no single reported reason that day.
+1.8% — Moved with the tape — no single reported reason that day.
+5.2% — Moved with the tape — no single reported reason that day.
+1.9% — Warren Buffett's Successor, Greg Abel, Just Sold UnitedHealth Group Stock. Is He Missing a Huge Opportunity?
-3.0% — Micron, UnitedHealth, Rocket Lab, and These Stocks Explain Today’s Market
+1.6% — Moved with the tape — no single reported reason that day.
-1.5% — Trump’s Portfolio Managers Traded UnitedHealth Ahead of Favorable Medicare Policy Change
The brief, in your inbox
One email every market morning. What moved, why, and what happened after.